Members |
acceptabilityId |
von Willebrand disease type 2B (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease type 2B (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease type 2M |
Preferred (foundation metadata concept) |
von Willebrand disease type 2M |
Preferred (foundation metadata concept) |
von Willebrand disease type 2M (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease type 2M (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease type 2N |
Acceptable (foundation metadata concept) |
von Willebrand disease type 2N |
Preferred (foundation metadata concept) |
von Willebrand disease type 2N (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease type 3 |
Acceptable (foundation metadata concept) |
von Willebrand disease type IA |
Preferred (foundation metadata concept) |
von Willebrand disease type IA |
Preferred (foundation metadata concept) |
von Willebrand disease type IA (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease type IA (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease type IB |
Acceptable (foundation metadata concept) |
von Willebrand disease type IC |
Acceptable (foundation metadata concept) |
von Willebrand disease type IIB |
Acceptable (foundation metadata concept) |
von Willebrand disease type III |
Acceptable (foundation metadata concept) |
von Willebrand disease, platelet type |
Acceptable (foundation metadata concept) |
von Willebrand disease, type 1^a^ |
Preferred (foundation metadata concept) |
von Willebrand disease, type 1^a^ (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIA |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIA (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIB |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIB (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIC |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIC (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IID |
Preferred (foundation metadata concept) |
von Willebrand disease, type IID (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIE |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIE (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIF |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIF (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIG |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIG (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIH |
Preferred (foundation metadata concept) |
von Willebrand disease, type IIH (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disease, type IS/III |
Preferred (foundation metadata concept) |
von Willebrand disease, type IS/III (disorder) |
Preferred (foundation metadata concept) |
von Willebrand disorder |
Preferred (foundation metadata concept) |
von Willebrand disorder (disorder) |
Preferred (foundation metadata concept) |
von Willebrand factor |
Preferred (foundation metadata concept) |
von Willebrand factor (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor activity |
Preferred (foundation metadata concept) |
von Willebrand factor activity |
Preferred (foundation metadata concept) |
von Willebrand factor activity (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor activity (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor antibody |
Preferred (foundation metadata concept) |
von Willebrand factor antibody (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor antigen |
Preferred (foundation metadata concept) |
von Willebrand factor antigen |
Preferred (foundation metadata concept) |
von Willebrand factor antigen (VWF:Ag) level |
Acceptable (foundation metadata concept) |
von Willebrand factor antigen (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor antigen (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor antigen level |
Preferred (foundation metadata concept) |
von Willebrand factor antigen level (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor antigen level measurement |
Acceptable (foundation metadata concept) |
von Willebrand factor below reference range |
Preferred (foundation metadata concept) |
von Willebrand factor below reference range (finding) |
Preferred (foundation metadata concept) |
von Willebrand factor collagen binding assay |
Preferred (foundation metadata concept) |
von Willebrand factor collagen binding assay (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor inhibitor |
Acceptable (foundation metadata concept) |
von Willebrand factor inhibitor disorder |
Preferred (foundation metadata concept) |
von Willebrand factor inhibitor disorder (disorder) |
Preferred (foundation metadata concept) |
von Willebrand factor level |
Preferred (foundation metadata concept) |
von Willebrand factor level |
Preferred (foundation metadata concept) |
von Willebrand factor level (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor level (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor multimer |
Preferred (foundation metadata concept) |
von Willebrand factor multimer (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor multimer assay |
Preferred (foundation metadata concept) |
von Willebrand factor multimer assay (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor multimeric analysis |
Preferred (foundation metadata concept) |
von Willebrand factor multimeric analysis (procedure) |
Preferred (foundation metadata concept) |
von Willebrand factor only product |
Preferred (foundation metadata concept) |
von Willebrand factor only product in parenteral dose form |
Preferred (foundation metadata concept) |
von Willebrand factor products allergy |
Preferred (foundation metadata concept) |
von Willebrand factor products allergy (disorder) |
Preferred (foundation metadata concept) |
von Willebrand factor ristocetin cofactor |
Acceptable (foundation metadata concept) |
von Willebrand factor ristocetin cofactor |
Preferred (foundation metadata concept) |
von Willebrand factor ristocetin cofactor (substance) |
Preferred (foundation metadata concept) |
von Willebrand factor-containing product |
Preferred (foundation metadata concept) |
von Willebrand factor-containing product in parenteral dose form |
Preferred (foundation metadata concept) |
von Willebrand receptor |
Preferred (foundation metadata concept) |
von Willebrand receptor (substance) |
Preferred (foundation metadata concept) |
von Willebrand screening test |
Preferred (foundation metadata concept) |
von Willebrand screening test (procedure) |
Preferred (foundation metadata concept) |
von Willebrand's disease |
Acceptable (foundation metadata concept) |
von Willebrand's disease |
Preferred (foundation metadata concept) |
von Willebrand's disease (disorder) |
Preferred (foundation metadata concept) |
von Willebrand-Jurgens disease |
Acceptable (foundation metadata concept) |
von Willebrand-Jürgens disease |
Acceptable (foundation metadata concept) |
w |
Preferred (foundation metadata concept) |
w-Amidase |
Preferred (foundation metadata concept) |
w-Amidase (substance) |
Preferred (foundation metadata concept) |
w-Hydroxydecanoate dehydrogenase |
Preferred (foundation metadata concept) |
w-Hydroxydecanoate dehydrogenase (substance) |
Preferred (foundation metadata concept) |
w-Protein |
Acceptable (foundation metadata concept) |
w-hydroxylase |
Acceptable (foundation metadata concept) |
w/v |
Preferred (foundation metadata concept) |
w/w |
Preferred (foundation metadata concept) |